How Small, But 'Mighty' TG Therapeutics Scored A 470% Gain Over 13 Months

Blockhead

02-12

TG Therapeutics (TGTX) Chief Executive Michael Weiss says his biotech company is small, but "mighty." But the move put up by TG stock over the last year has been anything but small. After hitting a fresh low in October 2023 below 7 a share, TG Therapeutics shares have rocketed more than 470%, touching a recent high near 37 in November…

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2511158570"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2511158570\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2511158570?lang=zh_TW&edition=fundamental","thumbnail":"https://www.investors.com/wp-content/uploads/2025/02/NEWAM_myelin_021425_adobe-150x150.jpg","is_english":true,"pubTime":"2025-02-12 21:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2511158570","market":"us","top_or_hot":-1,"title":"How Small, But 'Mighty' TG Therapeutics Scored A 470% Gain Over 13 Months","media":"Blockhead","content":"<html><body><div>\n<div><div></div><p>TG <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (TGTX) Chief Executive Michael Weiss says his biotech company is small, but \"mighty.\" But the move put up by TG stock over the last year has been anything but small. After hitting a fresh low in October 2023 below 7 a share, TG Therapeutics shares have rocketed more than 470%, touching a recent high near 37 in November…</p></div> </div></body></html>","source":"investor_business_daily_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>How Small, But 'Mighty' TG Therapeutics Scored A 470% Gain Over 13 Months</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHow Small, But 'Mighty' TG Therapeutics Scored A 470% Gain Over 13 Months\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Blockhead</strong><span class=\"h-time small\">2025-02-12 21:00</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><div>\n<div><div></div><p>TG <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (TGTX) Chief Executive Michael Weiss says his biotech company is small, but \"mighty.\" But the move put up by TG stock over the last year has been anything but small. After hitting a fresh low in October 2023 below 7 a share, TG Therapeutics shares have rocketed more than 470%, touching a recent high near 37 in November…</p></div> </div></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://www.investors.com/research/the-new-america/tg-therapeutics-tg-stock-briumvi-relapsing-multiple-sclerosis-ms/\">Blockhead</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TGTX","symbol_name":"TG Therapeutics Inc.","start_time":0,"source_url":"https://www.investors.com/research/the-new-america/tg-therapeutics-tg-stock-briumvi-relapsing-multiple-sclerosis-ms/","article_id":"2511158570","we_media_id":null,"thumbnails":["https://www.investors.com/wp-content/uploads/2025/02/NEWAM_myelin_021425_adobe-150x150.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2511158570","pubTimestamp":1739365240,"columns":[],"sourceInfo":{"source_id":"investor_business_daily_highlight","name":"Investor’s Business Daily"},"weMediaInfo":null,"summary":"TG Therapeutics CEO Michael Weiss says his biotech company is small, but \"mighty.\" But TG stock's move has been anything but small.","collect":0,"end_time":0,"defaultTopTitle":"investors.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TGTX":"TG Therapeutics Inc.","TG":"特里迪加","BK4153":"铝","BK4090":"商品化工","BK4585":"ETF&股票定投概念","BK4139":"生物科技","BK4588":"碎股"},"translate_title":"TG Therapeutics规模虽小，但“强大”，在13个月内实现了470%的增长","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TG":1,"TGTX":1},"content_text":"TG Therapeutics (TGTX) Chief Executive Michael Weiss says his biotech company is small, but \"mighty.\" But the move put up by TG stock over the last year has been anything but small. After hitting a fresh low in October 2023 below 7 a share, TG Therapeutics shares have rocketed more than 470%, touching a recent high near 37 in November…","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0}}}